Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GH Research PLC - Ordinary Shares (NQ:GHRS)

16.60 +0.76 (+4.80%)
Streaming Delayed Price Updated: 2:02 PM EST, Jan 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about GH Research PLC - Ordinary Shares

News headline image
Numinus Wellness, Seelos Therapeutics Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Cybin, GH Research Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Psyched: 9 US Reform Bills, Ayahuasca 'A Release' For Prince Harry, At-Home Therapy & More ↗
Psychedelics Bills Around The Country: 9 New Proposals, Several Passes, Several Fails And A Successful Local Decriminalization Throughout the 2023 session, numerous discussions have been... 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From March 6, 2023 ↗
 
Via Benzinga
News headline image
GH Resources: Focus On Treatment-Resistant Depression Paying Off ↗
A look at what GH Research is focused on, its latest quarterly financials, its stock price performance, and the price forecasts for the stock over the next 12 months. 
Via Talk Markets
News headline image
Here Are The Year's Highest Priced Psychedelics Stocks In US Markets ↗
After everything that's happened in the last several years, we believe it's safe to say that the psychedelic renaissance is a reality, one that Benzinga has consistently reported on.   
Via Benzinga
News headline image
Cybin, GH Research Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
GH Research 2022 R&D Expenses Grow 138% To $20.5M, What About Net Loss? ↗
GH Research PLC (NASDAQ: GHRS) released its financial results for the full year ended December 31, 2022, revealing R&D expenses were $20.5 million, a 138% increase compared to $8.6 million for the full... 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From March 2, 2023 ↗
 
Via Benzinga
News headline image
GH Research Reports Full Year 2022 Financial Results and Provides Business Updates
From GH Research PLC
Via GlobeNewswire
News headline image
Cybin, GH Research Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From February 28, 2023 ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From February 27, 2023 ↗
 
Via Benzinga
News headline image
Of The 6 Largest Psychedelic Drug Stocks, Only One Has Not Advanced YTD ↗
The most critical financial information on the health of a company is whether, or not, it has a Net Positive Operating Cash Flow; its Altman -Z Score; its Piotroski F-Score; and the percentage... 
Via Talk Markets
News headline image
Psychedelic Stock Gainers And Losers From February 24, 2023 ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From February 23, 2023 ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From February 22, 2023 ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From February 21, 2023 ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From February 20, 2023 ↗
 
Via Benzinga
News headline image
6 Largest Psychedelic Stocks Showing Strength; Up 11.5% YTD ↗
A look at the performance of the six largest psychedelic stocks by market capitalization. 
Via Talk Markets
News headline image
ATAI Life Sciences, GH Research Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Cybin, Compass Pathways Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From February 15, 2023 ↗
 
Via Benzinga
News headline image
GH Research, Mind Medicine Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Mind Medicine, GH Research Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
"Rags-To-Riches" Portfolio Down 8% Last Week ↗
Our newest Portfolio consists of 14 cannabis, psychedelic and plant-based food stocks with market capitalizations of at least $400M. It's holding above water YTD but was not able to hang onto last... 
Via Talk Markets
News headline image
Major Psychedelic Compound-Based Stocks UP 13% YTD ↗
We track the performance of the 6 largest companies researching the treatment of mental illnesses based on the use of one or more of 10 different psychedelic compound-based substances. 
Via Talk Markets
News headline image
Cybin, Seelos Therapeutics Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Seelos Therapeutics, Cybin Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From February 8, 2023 ↗
 
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.